Viyash Scientific Ltd Profit & Loss Annual

BSE: 512529 | NSE: VIYASH | ISIN: INE807F01027 | Sector: Biotechnology & Drugs

265.40 +4.85 (1.86%)Updated : 04 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	3,038.98	1,455.88	1,364.01	1,502.20
Other Net	8.53	1.00	3.00	-2.71
Diluted Weighted Average Shares	44.19	25.63	24.86	24.85
Gain( Loss)on Saleof Assets	3.61	6.02	5.54	2.04
Depreciation/ Amortization	233.64	66.45	61.54	55.69
Operating Income	381.33	95.49	5.72	-81.29
Net Income	177.29	21.88	-35.87	-121.16
Income Availableto Com Excl Extra Ord	177.29	21.88	-35.87	-121.16
Other Operating Expenses Total	43.72	33.15	29.32	26.07
Net Income Before Taxes	349.03	44.31	-54.65	-137.66
Minority Interest	-47.37	-10.38	-6.26	0.82
Net Income After Taxes	224.65	32.26	-29.61	-121.98
Income Availableto Com Incl Extra Ord	177.29	21.88	-35.87	-121.16
Costof Revenue Total	1,719.03	853.84	811.86	906.09
Gross Profit	1,701.27	697.54	557.87	514.82
Interest Inc( Exp) Net- Non- Op Total	-44.45	-58.20	-68.90	-55.70
Unusual Expense( Income)	39.28	5.25	17.56	65.94
Diluted Net Income	177.29	21.88	-35.87	-121.16
Provisionfor Income Taxes	124.37	12.05	-25.03	-15.68
period Type	-	-	-	-
Net Income Before Extra Items	177.29	21.88	-35.87	-121.16
Total Revenue	3,420.31	1,551.37	1,369.73	1,420.91
period Length	12.00	12.00	12.00	12.00
Revenue	3,420.31	1,551.37	1,369.73	1,420.91
Selling/ General/ Admin Expenses Total	1,003.30	497.19	443.74	448.40
Diluted Normalized EPS	4.53	0.83	-1.13	-3.20
Diluted EPS Excluding Extra Ord Items	4.01	0.85	-1.44	-4.88